Definium Therapeutics, Inc.
DFTX- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001813814
In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Definium Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 101 | 4 | 104 | +7 |
| Shares | 5.89M | 189.7K | 5.06M | −640.9K (−11.2%) |
| Value | $20.5M | $664.0K | $11.1M | −$8.73M (−44.0%) |
4 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (29)
Institutions that held Definium Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (22)
Institutions that held Definium Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| CVI Holdings, LLC | 652,374 | $2.28M |
| Group One Trading, L.P. | 62,534 | $219.0K |
| Swiss National Bank | 56,560 | $198.0K |
| Jane Street Group, LLC | 41,563 | $144.0K |
| Wolverine Trading, LLC | 29,939 | $103.0K |
| Credit Suisse AG | 22,306 | $78.0K |
| XTX Topco Ltd | 20,831 | $73.0K |
| The PNC Financial Services Group, Inc. | 13,535 | $47.0K |
| Commonwealth Equity Services, LLC | 12,491 | $43.0K |
| LMR Partners LLP | 10,211 | $36.0K |
| Equitec Proprietary Markets, LLC | 4,400 | $15.0K |
| Public Employees Retirement Association of Colorado | 1,880 | $9.00K |
| Toronto Dominion Bank | 1,960 | $7.00K |
| Shell Asset Management Co | 1,982 | $7.00K |
| Sandy Spring Bank | 810 | $3.00K |
| Glassman Wealth Services | 833 | $3.00K |
| Almanack Investment Partners, LLC. | 894 | $3.00K |
| Laffer Tengler Investments | 6 | $21 |
| Montag A & Associates Inc | 3 | $0 |
| Clearstead Advisors, LLC | 10 | $0 |
| Bogart Wealth, LLC | 100 | $0 |
| Professional Financial Advisors, LLC | 5 | $0 |
Not filed for Q4 2022 yet (4)
Institutions that held Definium Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Empery Asset Management, LP | 187,500 | $656.0K |
| American Portfolios Advisors | 2,000 | $7.00K |
| Covington Capital Management | 206 | $1.00K |
| Wipfli Financial Advisors LLC, | 6 | $0 |